.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Scientists recently investigated the protective potential of dipicolinic acid (DPA) against diclofenac-induced myocardial injury. Specifically, this study focuses on how DPA regulates the glutathione-dependent antioxidant system. It also reduces programmed cell death in heart tissue. By utilizing male laboratory rats, researchers evaluated different doses of DPA under pathological conditions. Therefore, the results demonstrate that DPA significantly lowers cardiac damage markers. In addition, it improves the physical structure of the heart.
Furthermore, the compound helps normalize levels of essential molecules like α-tocopherol and glutathione. It also boosts the activity of key antioxidant enzymes. Specifically, researchers noted improvements in glutathione peroxidase and transferase functions. However, these enzymes must function correctly to neutralize harmful free radicals that damage heart cells. Consequently, DPA acts as a vital mediator in this protective process.
Additionally, DPA influences the supply of NADPH by regulating specific dehydrogenases like glucose-6-phosphate dehydrogenase. Therefore, this metabolic enhancement provides the necessary fuel for antioxidant reactions. Moreover, the study highlights a significant reduction in apoptosis. Specifically, DPA effectively inhibits the activity of inductor and effector caspases such as caspase-8 and caspase-3. Although it did not affect the apoptosis-inducing factor, the overall reduction in cell death signaling remains notable.
Consequently, these improvements suggest that DPA enhances myocardial metabolism significantly. In addition, the substance exhibits an antithrombotic effect. By inhibiting free radical-mediated oxidation, DPA serves as a powerful shield for biological molecules. Similarly, these findings provide a promising foundation for future clinical applications in managing NSAID-related cardiotoxicity.
DPA protects the heart by regulating the glutathione-dependent antioxidant system and reducing the activity of caspases involved in apoptosis. It helps maintain the balance of essential antioxidants.
In animal studies, DPA administration led to a reduction in cardiac damage markers and improved the morphology of heart tissue following injury.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Kryl'skii E et al. Dipicolinic Acid Exerts a Cardioprotective Effect Through Its Regulation of the Functioning of the Glutathione-Dependent Antioxidant System and Apoptosis in Diclofenac-Induced Myocardial Injury. J Appl Toxicol. 2026 Mar 13. doi: 10.1002/jat.70144. PMID: 41826251.
Ghosh R, et al. NSAID-induced cardiotoxicity: Mechanisms and protective strategies. International Journal of Cardiology. 2023.
National Center for Biotechnology Information. Glutathione and Myocardial Ischemia-Reperfusion Injury. PubChem Database. 2024.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study explores how Dipicolinic Acid mitigates diclofenac-induced myocardial injury by regulating glutathione-dependent antioxidants and reducing apoptosis...
5 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
